Numerous studies have demonstrated the therapeutic potential of phytomolecules in preclinical cellular and animal PD models, with their ability to exert pleiotropic neuroprotective effects by targeting, inflammatory signaling, mitochondrial dysfunction, S aggregation, and key pathways including sirtuins and PI3K/Akt signaling (Zhong et al., 2019
Ileus: In September 2022, the FDA added Ileus as an adverse effect of Ozempic use
Ongoing studies are exploring the long-term effects of TZP, its cardiovascular benefits, and potential applications in other metabolic disorders, promising to significantly impact future treatment landscapes for T2D and obesity
According to a recent review in medical journals, retatrutide produced the top three results among all weight loss medications studied
As a result of COVID-19-related travel restrictions and lockdowns, the worldwide supply chain for GLP-1 receptor agonists was disrupted
There is no pharmacological requirement for this separation, but individual comfort matters for long-term adherence